The Ministry of Health and Prevention has signed a Memorandum of Understanding (MoU) with NewBridge Pharmaceuticals and Axios Gulf Companies, to launch an initiativefor the treatment of patients with rheumatoid who are not covered by health insurance, or a primary insurance that does not cover free treatment of this disease.
The MoU was signed at the ministry in Dubai by Dr. Amin Hussein Al Amiri, Assistant Under-Secretary for Public Policy and Licensing Sector of the UAE's Ministry of Health and Prevention, and Dr. Joseph Hanein, CEO of NewBridge Pharmaceuticals, and Dr. Anas Nofal, Regional Operations Manager at Axios Gulf.
Dr. Al Amiri said that the signing of the MoU with the two companies is a humanitarian and medical initiative that implements the strategy of the ministry to improve health services and scientific research, in accordance with the best international practices.
Source :WAM
GMT 10:31 2018 Tuesday ,13 November
Russian police uproot 70 underground drug labs in past six monthsGMT 16:32 2018 Tuesday ,06 November
Rwanda aims to achieve universal access to clean water by 2024GMT 16:57 2018 Sunday ,04 November
Palestinian women witness higher cure rate of breast cancerGMT 13:11 2018 Tuesday ,30 October
Emergency surgery saves life of touristGMT 10:44 2018 Tuesday ,23 October
Scientists find microplastics in human stool for first timeGMT 09:18 2018 Tuesday ,23 October
US judge upholds Monsanto weedkiller cancer verdict, reduces payoutGMT 14:22 2018 Friday ,19 October
Birth spacing ‘improving health of Omani women’GMT 15:40 2018 Monday ,15 October
Pakistani president launches nationwide anti-measles driveMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor